Prestige Consumer Healthcare (PBH) Interest & Investment Income (2011 - 2020)
Prestige Consumer Healthcare's (PBH) quarterly Interest & Investment Income came in at $24000.0 in Q2 2020, down 44.19% year-on-year from $43000.0 in Q3 2019, and up 9.09% quarter-over-quarter from $22000.0 in Q1 2020.
Prestige Consumer Healthcare (PBH) Interest & Investment Income (2011 - 2020) Analysis & Trends
Prestige Consumer Healthcare's Interest & Investment Income history runs 10 years deep, the most recent figure standing at $24000.0 for Q2 2020.
- On a quarterly basis, Interest & Investment Income fell 44.19% year-over-year to $24000.0 in Q2 2020; TTM through Jun 2020 was $323000.0, a 101.87% increase from a year earlier, with the FY2020 full-year figure at $342000.0, up 57.6% from the prior year.
- Interest & Investment Income improved to $24000.0 in Q2 2020 per PBH's latest filing, from $22000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $245000.0 in Q4 2019 and bottomed at $22000.0 in Q1 2020.
- The 5-year median for Interest & Investment Income is $50000.0 (2016), against an average of $69166.7.
- Across the five-year window, Interest & Investment Income plunged 67.23% in 2018 and jumped 528.21% in 2019, its largest moves.
- Year by year, Interest & Investment Income stood at $46000.0 in 2016, then soared by 158.7% to $119000.0 in 2017, then plunged by 67.23% to $39000.0 in 2018, then soared by 528.21% to $245000.0 in 2019, then slumped by 90.2% to $24000.0 in 2020.
- Per Business Quant, the three latest PBH Interest & Investment Income figures stand at $24000.0 (Q2 2020), $22000.0 (Q1 2020), and $245000.0 (Q4 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.41 Bn | 2.35 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 24,000.00 |
| Mar 31, 2020 | 22,000.00 |
| Dec 31, 2019 | 245,000.00 |
| Sep 30, 2019 | 32,000.00 |
| Jun 30, 2019 | 43,000.00 |
| Mar 31, 2019 | 45,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Sep 30, 2018 | 33,000.00 |
| Jun 30, 2018 | 100,000.00 |
| Mar 31, 2018 | 115,000.00 |
| Dec 31, 2017 | 119,000.00 |
| Sep 30, 2017 | 85,000.00 |
| Jun 30, 2017 | 69,000.00 |
| Mar 31, 2017 | 54,000.00 |
| Dec 31, 2016 | 46,000.00 |
| Sep 30, 2016 | 46,000.00 |
| Jun 30, 2016 | 57,000.00 |
| Mar 31, 2016 | 71,000.00 |
| Dec 31, 2015 | 31,000.00 |
| Sep 30, 2015 | 33,000.00 |